Navigation Links
Handbook of cancer prevention launched by ESMO
Date:2/11/2008

A new publication designed to help individuals, doctors and governments reduce the global burden of cancer has been announced today by Europes leading society for medical oncologists.

The ESMO Handbook of Cancer Prevention, from the European Society for Medical Oncology, contains state-of-the-art, practical guidance on reducing cancer risk, screening for tumors and preventing their spread.

"Every year, more than 10 million people around the world develop cancer," says Professor David Kerr, ESMO President-Elect. "The reality is that many of those cases could be prevented--whether by giving up smoking, changing diet, avoiding infectious diseases or by national screening programs."

In order to increase awareness, ESMO's handbook of 22 chapters brings together vital information on preventing a range of cancers, including those that affect the lungs, cervix, breast, prostate and colon. Chapters devoted to tobacco, alcohol, nutrition, workplace risks and hereditary cancer provide recommendations on the best ways to reduce cancer risk.

"ESMO believes that time has come for cancer prevention to be given the highest possible priority, and we hope this handbook will serve as a practical tool in that effort," says Professor Hans-Joerg Senn, Chair of the ESMO Cancer Prevention Working Group.

"In the near future medical oncologists will play a greater role in different aspects of cancer prevention, especially in chemo- and bio-prevention of important tumors such as breast cancer," Prof. Senn adds. "And as new technologies such as anticancer vaccines become available, that role will become increasingly important."

The handbook is part of a wider commitment from ESMO to promote the importance of cancer prevention.

This week, ESMO Past-President Professor Hakan Mellstedt will give an invited presentation at an event in Brussels organized by the group 'Members of the European Parliament Against Cancer' (MAC) in collab
'/>"/>

Contact: Vanessa Pavinato
media@esmo.org
41-919-731-907
European Society for Medical Oncology
Source:Eurekalert

Page: 1 2

Related medicine news :

1. The Handbook of Proteins
2. NHCAA Releases Fraud Fighters Handbook Outlining Strategies to Protect the Public Against Health Care Fraud
3. Anti-cancer drug damages brain vessels
4. Most Breast Cancer Web Pages Contain Reliable Information
5. More Gene Variations Found That Raise Prostate Cancer Risk
6. U.S. Representatives Urge Critical Improvements in Prostate Cancer Detection
7. Provider influence and patient barriers affect use of colorectal cancer screening
8. Predictors of inaccurate online breast cancer information
9. Review of online breast cancer information encourages healthy skepticism for consumers
10. Study reveals why certain ovarian cancers develop resistance to platinum-based chemotherapy
11. Seattle Cancer Care Alliance and Northwest Hospital Sign Letter of Intent to Develop Proton Therapy Center for Cancer Treatment
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/24/2008)... MONROVIA, Calif., July 24 /PRNewswire-FirstC... leading developer, manufacturer and marketer of,m...nced that the Centers,for Medicare and Medicaid Se...heric cataract lenses as New Technology Intraocula...amer(R) Aspheric Single Piece foldable,intraocular...
(Date:7/24/2008)... Ground-breaking Technology Debuts in the Trance... Shoe, BOTHELL, Wash., July 24 /PRNewswi...Sports, Inc. today announced that BioMoGo, the wor... to consumers in the new Trance(TM),8 premium supp... times,faster than conventional athletic shoe mids...
(Date:7/24/2008)... NEW YORK, July 24 /PRNewswire/ -- MS -- Toda...nt things. For those who care for their,bodies, by...ations for,anti-aging, it is possible to feel and ...http://www.newscom.com/cgi-bin/prnh/20080724/NYFNS...uthor, and frequent guest on,Oprah Winfrey,s progr...
(Date:7/24/2008)... SCHAUMBURG, Ill., July 24 /PRNewswire/ -- A ...America,s most chronic problems -- obesity -- in,p... weight problem. About one third of us are,obese, ...ets -- they really,do look like us -- mirror us wi...esity, a public/private partnership that includes,...
Breaking Medicine News(10 mins):Health News:STAAR Surgical's Collamer(R) IOL and Elastimide(R) IOL Each Recognized with New Technology Intraocular Lens Classification 2Health News:STAAR Surgical's Collamer(R) IOL and Elastimide(R) IOL Each Recognized with New Technology Intraocular Lens Classification 3Health News:STAAR Surgical's Collamer(R) IOL and Elastimide(R) IOL Each Recognized with New Technology Intraocular Lens Classification 4Health News:Brooks(R) Sports Launches BioMoGo Biodegradable Shoe 2Health News:Brooks(R) Sports Launches BioMoGo Biodegradable Shoe 3Health News:Live to 100 ... And Feel Great 2Health News:PetFit Challenge Helps Keep Pets - and Pet Owners - Healthy 2
...ndia has declined over the century from 972 in 190... to 933 in 2001. In contrast, the child sex rati...rls per thousand boys against 945 recorded in 1991...tio is concerned, it is 1.01 male (s)/females as i...
...ntessentially Indian puff, has become a victim of ...outhern districts of Tamil Nadu going on strike. ...wrapped in leaf, from Tirunelveli, Tuticorin and K...this weekend to protest the union health ministry ...
...Democratic Front (LDF) government, set to mark its...at it is to blame for the deaths of 38 newborns in...fection in the labour room of the Sree Avittam Tir...the last two months. A court has charged Health M...
...is of concern as it is a reflection of the prevale...s and the extent of transmission of TB infection ...orted under the programme are of paediatric age gr...ntage of paediatric cases reported at national lev...
Other Medicine News:Health News:Bidi Workers Protest Against Using Skull and Crossbones Sign on Packets 2
(Date:7/23/2008)...py to Treat the Disease -, WAYNE, N.J. and EMERYV...yer HealthCare Pharmaceuticals and Onyx Pharmaceut...e New England Journal of Medicine published,result... (sorafenib),tablets decreased the absolute risk o...e hepatocellular carcinoma (HCC), or liver cancer,...
(Date:7/23/2008).../ -- The following was,released by the U.S. Depart...r Smith, and Members of the Committee.,Thank you f...eared before this Committee almost six months ago,...ented and dedicated professionals,at the Justice D...me to,appreciate that much more deeply their servi...
(Date:7/23/2008)...ode BioPharmaceutics, Inc.,an emerging biopharmac...results demonstrating the utility of their lead dr...hronic blood disorder paroxysmal nocturnal,hemoglo...ted at the XXII,International Complement Workshop ...nly treatment currently available for PNH patients...
(Date:7/22/2008)...irstCall/ -- Following a,thorough review that conc...uticals Limited (ASX: PGL; Nasdaq: PGLA) today ann...study in liver cancer. Progen confirmed,its strate... compounds and,the company will actively seek to a...ugh Merger & Acquisition activity., The strategic...
Breaking Medicine Technology:The New England Journal of Medicine Publishes Nexavar(R) Study Demonstrating Significant Improvement in Overall Survival in Patients With Liver Cancer 2The New England Journal of Medicine Publishes Nexavar(R) Study Demonstrating Significant Improvement in Overall Survival in Patients With Liver Cancer 3The New England Journal of Medicine Publishes Nexavar(R) Study Demonstrating Significant Improvement in Overall Survival in Patients With Liver Cancer 4The New England Journal of Medicine Publishes Nexavar(R) Study Demonstrating Significant Improvement in Overall Survival in Patients With Liver Cancer 5The New England Journal of Medicine Publishes Nexavar(R) Study Demonstrating Significant Improvement in Overall Survival in Patients With Liver Cancer 6Prepared Remarks of Attorney General Michael B. Mukasey Before the House Judiciary Committee 2Prepared Remarks of Attorney General Michael B. Mukasey Before the House Judiciary Committee 3InCode BioPharmaceutics, Inc. Announces Key Data Supporting New Treatment of Paroxysmal Nocturnal Hemoglobinuria (PNH) 2Progen Terminates PATHWAY Trial & Confirms Focus on Potential High Value Molecules and M&A 2Progen Terminates PATHWAY Trial & Confirms Focus on Potential High Value Molecules and M&A 3Emisphere Announces Second Study Demonstrating Dramatic Increases in Absorption of Oral B12 Using eligen 28R 29 Technology at Lower Doses 1558 1Emisphere Announces Second Study Demonstrating Dramatic Increases in Absorption of Oral B12 Using eligen 28R 29 Technology at Lower Doses 1558 2Emisphere Announces Second Study Demonstrating Dramatic Increases in Absorption of Oral B12 Using eligen 28R 29 Technology at Lower Doses 1558 3Varian Announces Global Clinical Council to Develop RapidArc 28TM 29 Cancer Treatments 14693 1Varian Announces Global Clinical Council to Develop RapidArc 28TM 29 Cancer Treatments 14693 2Varian Announces Global Clinical Council to Develop RapidArc 28TM 29 Cancer Treatments 14693 3Varian Announces Global Clinical Council to Develop RapidArc 28TM 29 Cancer Treatments 14693 4Varian Announces Global Clinical Council to Develop RapidArc 28TM 29 Cancer Treatments 14693 5National Parkinson Foundation Announces Its New President and CEO 14689 1National Parkinson Foundation Announces Its New President and CEO 14689 2National Parkinson Foundation Announces Its New President and CEO 14689 3Michigan State Medical Society Will Present How VEBA is Shifting Michigans Health Care Gears 14686 1
... -- Additional Findings Reported Safety & Tole...and Healthy Subjects --, CHICAGO, June 25, 2007 /P...his week at the annual meeting of the American Dia...n inhibitor of,dipeptidyl-peptidase-4 (DPP-4) in d...raZeneca , in combination with metformin,exhibite...
... ,Focus On AV411,s Unique Mechanism of Action an...l Conditions , ALAMEDA, Calif., June 26, 2007 (PRI...harmaceutical company innovating therapeutics,for ...d today that,Expert Opinion on Investigational Dru...eline product, AV411 (ibudilast), a potential,firs...
Other Medicine Technology:Data Demonstrated Saxagliptin Added to Metformin Improved Glycemic,Control in Subjects with Type 2 Diabetes Compared to Metformin,Alone 2Data Demonstrated Saxagliptin Added to Metformin Improved Glycemic,Control in Subjects with Type 2 Diabetes Compared to Metformin,Alone 3Data Demonstrated Saxagliptin Added to Metformin Improved Glycemic,Control in Subjects with Type 2 Diabetes Compared to Metformin,Alone 4Data Demonstrated Saxagliptin Added to Metformin Improved Glycemic,Control in Subjects with Type 2 Diabetes Compared to Metformin,Alone 5Data Demonstrated Saxagliptin Added to Metformin Improved Glycemic,Control in Subjects with Type 2 Diabetes Compared to Metformin,Alone 6Expert Opinion Highlights Avigen's AV411 as Potential New,Therapeutic for Neuropathic Pain and Opioid Withdrawal 2Expert Opinion Highlights Avigen's AV411 as Potential New,Therapeutic for Neuropathic Pain and Opioid Withdrawal 3Expert Opinion Highlights Avigen's AV411 as Potential New,Therapeutic for Neuropathic Pain and Opioid Withdrawal 4Expert Opinion Highlights Avigen's AV411 as Potential New,Therapeutic for Neuropathic Pain and Opioid Withdrawal 5
Anti Gliadin IgA Enzyme Immunosay for quantitative determination of Gliadin-IgG antibodies in serum.
...igned as a high throughput primary or backup instr...r offers performance and reliability equal to or g...advanced technology of the AUTION JET AJ-4270 and ...ate results, limiting interference from elevated p...
Assay uses highly specific rabbit anti-estriol antibody reparation - negligible cross-reactivity with other estrogen metabolites. Excellent assay precision and reproducibility. Superior sensitivity
...rone Sulfate (E1S) is the most abundant circulatin... men [1,2]. Estrone Sulfate is a major metabolite ...fe in blood [2,3]. In premenopausal women, estrone...e and estradiol, rising gradually during the folli...
Medicine Products: